Skip to main content
UPC
NASDAQ Life Sciences

Universe Pharmaceuticals Files $200M Shelf and Registers 87% of Outstanding Shares for Resale

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$4.52
Mkt Cap
$22.71M
52W Low
$2
52W High
$17.96
52W Position info
126% above low
Off High info
75% below high
Rel. Volume
Market data snapshot near publication time

UPC has more than doubled off its 52-week low of $2.

Summary

Universe Pharmaceuticals registered a $200M universal shelf and 4.38M shares for resale by selling shareholders, representing ~87% of outstanding Class A shares. The filing also discloses a new Nasdaq delisting risk tied to a $5M minimum market value rule.


Key Events · Financing and Capital Events · UPC

  • $200M Universal Shelf Registered

    The company registered up to $200 million of Class A ordinary shares, debt securities, warrants, rights, and units for sale from time to time.

  • 87% of Outstanding Shares Registered for Resale

    4,376,552 Class A ordinary shares held by selling shareholders were registered for resale, representing approximately 87.39% of the 5,008,313 Class A shares outstanding.

  • Substantial Overhang on Stock

    The resale registration creates a significant overhang that could depress the stock price for an extended period, regardless of whether the selling shareholders actually sell.

  • Nasdaq Delisting Risk Disclosed

    A new Nasdaq rule requiring a $5 million minimum market value could result in immediate delisting with no cure period if implemented; the rule is currently suspended pending SEC review.


Analysis · UPC · Life Sciences

Universe Pharmaceuticals filed a new $200 million universal shelf registration and registered 4,376,552 Class A ordinary shares for resale by selling shareholders — approximately 87.39% of the company's outstanding Class A shares. The resale registration creates a substantial overhang: even modest sales by the selling shareholders could have an outsized impact on the stock price given the company's limited trading volume. The filing also discloses a new Nasdaq minimum market value rule that, if implemented, could result in immediate delisting with no cure period — a material governance and listing risk for a company with a market cap of approximately $22.7 million.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, UPC was trading at $4.52 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $22.7M. The 52-week trading range was $2.00 to $17.96. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

UPC - Latest Insights

UPC
Sep 01, 2026, 5:25 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.27
Real-time Price: $1.61 info
Change: -$2.66 (-62%) info
Market Cap: $8.087M info
UPC
Jul 31, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $3.88
Real-time Price: $1.61 info
Change: -$2.27 (-59%) info
Market Cap: $8.087M info
UPC
Jul 29, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.26
Real-time Price: $1.61 info
Change: -$1.65 (-51%) info
Market Cap: $8.087M info
UPC
Jun 26, 2026, 4:06 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $4.46
Real-time Price: $1.61 info
Change: -$2.85 (-64%) info
Market Cap: $8.087M info
UPC
Jun 26, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $3.03
Real-time Price: $1.61 info
Change: -$1.42 (-47%) info
Market Cap: $8.087M info